United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 5 minute read Technology Industry News Wipro Q1 FY26 results: Can strong large deal wins and AI-led strategy offset the revenue slowdown? Wipro Q1 FY26 bookings surged 131% YoY amid revenue softness. Can AI-led mega deals drive growth recovery in the second half of FY26? byPallavi MadhirajuJuly 28, 2025